CLDI Insider Trading Activity and SEC Form 4 Filings
CLDI insider trading summary
Over the past 12 months, insiders at Calidi Biotherapeutics, Inc. (CLDI) reported 1 sale worth $1K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $1K.
Latest CLDI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 12, 2025 | Allan Camaisa | Director | Sell | $1K (850 @ $1.46) |
| Aug 21, 2025 | Eric E Poma | Chief Executive Officer | Buy | $50K (25,000 @ $2.00) |
| Aug 21, 2025 | James A Schoeneck | Director | Buy | $150K (75,000 @ $2.00) |
| Aug 21, 2025 | Andrew C. Jackson | Chief Financial Officer | Buy | $5K (2,500 @ $2.00) |
| Aug 21, 2025 | Scott Leftwich | Director | Buy | $250K (125,000 @ $2.00) |
| Dec 17, 2024 | Allan Camaisa | CEO and Chairman of the Board | Sell | $16K (10,000 @ $1.62) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.